By Deena Beasley Nov 3 (Reuters) – Amgen on Tuesday said third-quarter sales rose 8%, led by cholesterol drug Repatha and newer medicines Imdelltra for lung cancer and rare disease therapy Uplizna, as
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
RUSSIA'S OZON SAYS ONE OF ITS LOGISTIC HUBS HIT BY DRONES (The article has been…
Nov 3 (The Insurer) - Verdant Rock has hired Carolyn Thomas, Kevin Downs and Sarah…
Nov 3 (Reuters) - CVS Health is considering a breakup of its healthcare empire that…
By David Shepardson WASHINGTON, Nov 3 (Reuters) - The US Senate Commerce Committee will hold…
Nov 3 (The Insurer) - Epic Insurance Brokers & Consultants has acquired the boutique personal…
VIDEO SHOWS: MINUTE'S SILENCE HELD AT THE METROPOLITANO STADIUM AND CAMP NOU IN MEMORY OF TENERIFE…